Method for activating regulatory t-cells

Details for Australian Patent Application No. 2008290827 (hide)

Owner IMTM GmbH

Inventors Wolke, Carmen; Tager, Michael; Tadje, Janine; Bank, Ute; Lendeckel, Uwe; Ansorge, Siegfried

Agent Cullens

Pub. Number AU-B-2008290827

PCT Pub. Number WO2009/024348

Priority 10 2007 039 429.4 21.08.07 DE

Filing date 21 August 2008

Wipo publication date 26 February 2009

Acceptance publication date 9 June 2011

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2009/024348 Priority application(s): WO2009/024348

9 June 2011 Application Accepted

  Published as AU-B-2008290827

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008290857-Cell carrier containing collagen

2008290825-The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases